Literature DB >> 29842848

Lactobacillus gasseri PA-3, but not L. gasseri OLL2996, reduces the absorption of purine nucleosides in rats.

H Kano1, N Yamada1, C Saito1, Y Murayama-Chiba1, Y Asami1, H Ito1.   

Abstract

Lactobacillus gasseri PA-3 (PA-3) is a bacterial strain with a strong ability to degrade purine nucleosides. We previously showed that PA-3 incorporates purines in vitro and that oral administration of PA-3 and purines to rats attenuated their absorption of purines. It remains unclear whether these effects of PA-3 depend on bacterial strains. This study therefore compared the abilities of PA-3 and another bacterial strain of L. gasseri, OLL2996, which has shown decreased ability to degrade purine nucleosides in vitro, to incorporate purine nucleosides and to inhibit the absorption of purines fed to rats. Each bacterial strain was incubated in the presence of 14C-adenosine or 14C-inosine and the incorporation of each purine was evaluated by measuring their radioactivity. In vivo, rats were fed 14C-labeled purines along with PA-3 or OLL2996 and the absorption of these 14C-labeled purines was evaluated by analyzing radioactivity of blood samples. PA-3 incorporated about twice as much 14C-adenosine and 14C-inosine as OLL2996. The elevation of radioactivity levels in blood was 10-20% lower in rats treated with PA-3 than in control rats, after feeding with both 14C-adenosine and 14C-inosine as purines. In contrast, treatment with OLL2996 did not have statistically significant effects on radioactivity compared with the control group. These results indicate that the magnitude of bacterial inhibition of purine absorption is dependent on bacterial strain, correlating at least partly with the ability to incorporate and degrade purines.

Entities:  

Keywords:  Lactic acid bacteria; Lactobacillus gasseri PA-3; purine absorption

Mesh:

Substances:

Year:  2018        PMID: 29842848     DOI: 10.1080/15257770.2018.1469760

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  5 in total

1.  Potential Probiotic Lacticaseibacillus paracasei MJM60396 Prevents Hyperuricemia in a Multiple Way by Absorbing Purine, Suppressing Xanthine Oxidase and Regulating Urate Excretion in Mice.

Authors:  Youjin Lee; Pia Werlinger; Joo-Won Suh; Jinhua Cheng
Journal:  Microorganisms       Date:  2022-04-20

2.  Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats.

Authors:  Yi-Wei Kuo; Shih-Hung Hsieh; Jui-Fen Chen; Cheng-Ruei Liu; Ching-Wei Chen; Yu-Fen Huang; Hsieh-Hsun Ho
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

3.  Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment.

Authors:  Rui Zhao; Zimai Li; Yuqing Sun; Wei Ge; Mingyu Wang; Huaiwei Liu; Luying Xun; Yongzhen Xia
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid.

Authors:  Shuai Zhao; Pengya Feng; Xiaogang Hu; Wenjuan Cao; Pu Liu; Huawen Han; Weilin Jin; Xiangkai Li
Journal:  iScience       Date:  2022-09-28

5.  Effect of Lactobacillus gasseri PA3 on gut microbiota in an in vitro colonic simulation.

Authors:  Shasha Xiang; Jian Fu; Kun Ye; Yiqing Zheng; Xuan Zhu; Jie Chen; Yuewen Chen
Journal:  Food Sci Nutr       Date:  2019-11-14       Impact factor: 2.863

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.